Results 21 to 30 of about 31,265 (205)

POTENTIATION OF THE HYPOTENSIVE EFFECT OF CAPTOPRIL BY THE H2 BLOCKER CIMETIDINE IN THE NORMOTENSIVE ANAESTHETIZED RATS

open access: yesZagazig Journal of Pharmaceutical Sciences, 1993
The effects of captopril (1 mg/kg), cimetidine (25 mg/kg), and their combination on the arterial blood pressure, heart rate, ECG and the calculated double product of anaesthetized normotensive rats were investigated.
Salah Ghareib   +2 more
doaj   +1 more source

A histopathological evaluation on the effect of captopril in cyclophosphamide-induced hemorrhagic cystitis [PDF]

open access: yesTrends in Pharmaceutical Sciences, 2021
Cyclophosphamide is one of the most prescribed antineoplastic agents. Hemorrhagic cystitis is one of the most common side effects of cyclophosphamide. Captopril is usually used as an anti-blood pressure agent.
Nahid Ahmadi   +6 more
doaj   +1 more source

Protective effect of captopril against methotrexate- induced nephrotoxicity in mice

open access: yesKufa Journal for Veterinary Medical Sciences, 2010
The present study was designed to investigate some histopathological changes produced by methotrexate on kidney in mice and extended to examine whether there using captopril have ability to reduce this toxicity.
Atiaf G. R. AL-Nailey
doaj   +1 more source

Special uses for captopril

open access: yes, 1987
Plasma renin activity (PRA) is markedly increased by captopril. There is not enough separation between the changes in PRA of patients with renal artery stenosis (RAS) to separate them reliably from those with essential hypertension.
Materson, B J
core   +3 more sources

Electrocatalytic determination of captopril using a carbon paste electrode modified with N-(ferrocenyl methylidene) fluorene-2-amine and graphene/ZnO nanocomposite [PDF]

open access: yesJournal of the Serbian Chemical Society, 2019
A carbon paste electrode (CPE) was modified with N-(ferrocenylmethylidene) fluorene-2-amine and graphene/ZnO nanocomposite. The electrooxidation of captopril (CAP) at the surface of the modified electrode was studied using electrochemical approaches. The
Safaei Mohadeseh   +4 more
doaj   +1 more source

Tablet of captopril with a cross-linked system of alginate [PDF]

open access: yes, 2007
Captopril has a short biological half life (1-3h) and has been used for long-term treatment of hypertension. The properties of captopril such as freely water-soluble and instability in intestinal environment lead to the difficulty of developing captopril
Rachmawati, Heni; School of Pharmacy Institut Teknologi Bandung   +2 more
core   +1 more source

Bullous Pemphigoid Associated with Captopril

open access: yes, 1989
Captopril is commonly prescribed to patients with hypertension and congestive heart failure. Adverse dermatological reactions have been reported in about ten percent of patients receiving captopril.
James W. Cooper   +2 more
core   +1 more source

Electrochemical and Computational Studies of Proline and Captopril as Corrosion Inhibitors on Carbon Steel in a Phase Change Material Solution

open access: yesInternational Journal of Electrochemical Science, 2020
In this paper, electrochemical and surface analysis methods were used to study the corrosion inhibition performance of proline and captopril on 1045 carbon steel in phase change materials (PCMs).
Wenwu Li   +5 more
doaj   +1 more source

Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial. [PDF]

open access: yesPLoS ONE, 2017
Changes during the puerperium are still unclear, particularly in women with hypertension. The choice of antihypertensives, both to control very high blood pressure episodes and to keep blood pressure stable, also requires further elucidation.
Carlos Noronha Neto C   +5 more
doaj   +1 more source

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy